x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF |
THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from | to |
Florida | No. 59-1517485 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |
Large accelerated filer x | Accelerated filer o | |
Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o | |
Emerging growth company o |
INDEX | |||
PAGE | |||
PART I | |||
Item 1. | |||
Condensed Consolidated Statements of Financial Condition as of March 31, 2017 and September 30, 2016 (Unaudited) | |||
Condensed Consolidated Statements of Income and Comprehensive Income for the three and six months ended March 31, 2017 and March 31, 2016 (Unaudited) | |||
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the six months ended March 31, 2017 and March 31, 2016 (Unaudited) | |||
Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2017 and March 31, 2016 (Unaudited) | |||
Note 1 - Introduction and basis of presentation | |||
Note 2 - Update of significant accounting policies | |||
Note 3 - Acquisitions | |||
Note 4 - Cash and cash equivalents, assets segregated pursuant to regulations, and deposits with clearing organizations | |||
Note 5 - Fair value | |||
Note 6 - Trading instruments and trading instruments sold but not yet purchased | |||
Note 7 - Available for sale securities | |||
Note 8 - Bank loans, net | |||
Note 9 - Variable interest entities | |||
Note 10 - Goodwill and identifiable intangible assets | |||
Note 11 - Bank deposits | |||
Note 12 - Other borrowings | |||
Note 13 - Senior notes payable | |||
Note 14 - Derivative financial instruments | |||
Note 15 - Disclosure of offsetting assets and liabilities, collateral, encumbered assets and repurchase agreements | |||
Note 16 - Income taxes | |||
Note 17 - Commitments, contingencies and guarantees | |||
Note 18 - Accumulated other comprehensive income (loss) | |||
Note 19 - Interest income and interest expense | |||
Note 20 - Share-based compensation | |||
Note 21 - Regulatory capital requirements | |||
Note 22 - Financial instruments with off-balance sheet risk | |||
Note 23 - Earnings per share | |||
Note 24 - Segment information | |||
Item 2. | |||
Item 3. | |||
Item 4. | |||
PART II | |||
Item 1. | |||
Item 1A. | |||
Item 2. | Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities | ||
Item 3. | |||
Item 5. | |||
Item 6. | |||
March 31, 2017 | September 30, 2016 | ||||||
(in thousands) | |||||||
Assets: | |||||||
Cash and cash equivalents | $ | 2,636,326 | $ | 1,650,452 | |||
Assets segregated pursuant to regulations and other segregated assets | 3,829,607 | 4,884,487 | |||||
Securities purchased under agreements to resell and other collateralized financings | 535,224 | 470,222 | |||||
Financial instruments, at fair value: | |||||||
Trading instruments | 736,782 | 766,805 | |||||
Available for sale securities | 1,714,114 | 859,398 | |||||
Private equity investments | 201,761 | 194,634 | |||||
Other investments | 222,585 | 296,844 | |||||
Derivative instruments associated with offsetting matched book positions | 285,898 | 422,196 | |||||
Receivables: | |||||||
Brokerage clients, net | 2,716,741 | 2,714,782 | |||||
Stock borrowed | 132,049 | 170,860 | |||||
Bank loans, net | 15,994,689 | 15,210,735 | |||||
Brokers-dealers and clearing organizations | 97,807 | 164,908 | |||||
Loans to financial advisors, net | 861,346 | 838,721 | |||||
Other | 645,845 | 610,417 | |||||
Deposits with clearing organizations | 199,096 | 245,364 | |||||
Prepaid expenses and other assets | 787,588 | 777,224 | |||||
Investments in real estate partnerships held by consolidated variable interest entities | 59,639 | 61,004 | |||||
Property and equipment, net | 409,543 | 321,457 | |||||
Deferred income taxes, net | 365,869 | 322,024 | |||||
Goodwill and identifiable intangible assets, net | 496,222 | 504,442 | |||||
Total assets | $ | 32,928,731 | $ | 31,486,976 |
March 31, 2017 | September 30, 2016 | ||||||
($ in thousands) | |||||||
Liabilities and equity: | |||||||
Trading instruments sold but not yet purchased, at fair value | $ | 471,704 | $ | 328,938 | |||
Securities sold under agreements to repurchase | 222,476 | 193,229 | |||||
Derivative instruments associated with offsetting matched book positions, at fair value | 285,898 | 422,196 | |||||
Payables: | |||||||
Brokerage clients | 6,073,591 | 6,444,671 | |||||
Stock loaned | 403,542 | 677,761 | |||||
Bank deposits | 16,377,544 | 14,262,547 | |||||
Brokers-dealers and clearing organizations | 228,661 | 306,119 | |||||
Trade and other | 629,598 | 583,340 | |||||
Other borrowings | 756,367 | 608,658 | |||||
Accrued compensation, commissions and benefits | 811,551 | 915,954 | |||||
Senior notes payable | 1,339,582 | 1,680,587 | |||||
Total liabilities | 27,600,514 | 26,424,000 | |||||
Commitments and contingencies (see Note 17) | |||||||
Equity | |||||||
Preferred stock; $.10 par value; 10,000,000 shares authorized; -0- shares issued and outstanding | — | — | |||||
Common stock; $.01 par value; 350,000,000 shares authorized; 153,716,695 and 151,424,947 shares issued as of March 31, 2017 and September 30, 2016, respectively, and 143,542,965 and 141,544,511 shares outstanding as of March 31, 2017 and September 30, 2016, respectively | 1,536 | 1,513 | |||||
Additional paid-in capital | 1,595,314 | 1,498,921 | |||||
Retained earnings | 4,027,927 | 3,834,781 | |||||
Treasury stock, at cost; 10,101,753 and 9,766,846 common shares as of March 31, 2017 and September 30, 2016, respectively | (389,595 | ) | (362,937 | ) | |||
Accumulated other comprehensive loss | (27,434 | ) | (55,733 | ) | |||
Total equity attributable to Raymond James Financial, Inc. | 5,207,748 | 4,916,545 | |||||
Noncontrolling interests | 120,469 | 146,431 | |||||
Total equity | 5,328,217 | 5,062,976 | |||||
Total liabilities and equity | $ | 32,928,731 | $ | 31,486,976 |
Three months ended March 31, | Six months ended March 31, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
(in thousands, except per share amounts) | |||||||||||||||
Revenues: | |||||||||||||||
Securities commissions and fees | $ | 992,112 | $ | 853,330 | $ | 1,976,497 | $ | 1,702,992 | |||||||
Investment banking | 102,377 | 68,704 | 163,802 | 126,257 | |||||||||||
Investment advisory and related administrative fees | 110,280 | 93,871 | 218,523 | 192,473 | |||||||||||
Interest | 192,544 | 161,638 | 375,326 | 304,110 | |||||||||||
Account and service fees | 162,981 | 127,528 | 311,772 | 244,351 | |||||||||||
Net trading profit | 15,811 | 14,415 | 36,366 | 36,584 | |||||||||||
Other | 24,209 | 21,624 | 46,796 | 35,200 | |||||||||||
Total revenues | 1,600,314 | 1,341,110 | 3,129,082 | 2,641,967 | |||||||||||
Interest expense | (36,677 | ) | (29,109 | ) | (72,643 | ) | (55,808 | ) | |||||||
Net revenues | 1,563,637 | 1,312,001 | 3,056,439 | 2,586,159 | |||||||||||
Non-interest expenses: | |||||||||||||||
Compensation, commissions and benefits | 1,035,714 | 887,937 | 2,042,181 | 1,754,335 | |||||||||||
Communications and information processing | 76,067 | 68,482 | 148,228 | 140,620 | |||||||||||
Occupancy and equipment costs | 47,498 | 40,891 | 93,550 | 82,680 | |||||||||||
Clearance and floor brokerage | 11,407 | 10,517 | 23,757 | 20,513 | |||||||||||
Business development | 41,519 | 35,417 | 76,881 | 76,041 | |||||||||||
Investment sub-advisory fees | 17,778 | 14,282 | 37,073 | 28,836 | |||||||||||
Bank loan loss provision | 7,928 | 9,629 | 6,888 | 23,539 | |||||||||||
Acquisition-related expenses | 1,086 | 6,015 | 13,752 | 7,887 | |||||||||||
Other | 163,337 | 44,723 | 245,311 | 87,527 | |||||||||||
Total non-interest expenses | 1,402,334 | 1,117,893 | 2,687,621 | 2,221,978 | |||||||||||
Income including noncontrolling interests and before provision for income taxes | 161,303 | 194,108 | 368,818 | 364,181 | |||||||||||
Provision for income taxes | 52,758 | 72,271 | 112,570 | 134,280 | |||||||||||
Net income including noncontrolling interests | 108,545 | 121,837 | 256,248 | 229,901 | |||||||||||
Net loss attributable to noncontrolling interests | (4,210 | ) | (4,010 | ) | (3,074 | ) | (2,275 | ) | |||||||
Net income attributable to Raymond James Financial, Inc. | $ | 112,755 | $ | 125,847 | $ | 259,322 | $ | 232,176 | |||||||
Net income per common share – basic | $ | 0.78 | $ | 0.89 | $ | 1.81 | $ | 1.63 | |||||||
Net income per common share – diluted | $ | 0.77 | $ | 0.87 | $ | 1.77 | $ | 1.60 | |||||||
Weighted-average common shares outstanding – basic | 143,367 | 141,472 | 142,732 | 142,273 | |||||||||||
Weighted-average common and common equivalent shares outstanding – diluted | 146,779 | 144,012 | 146,119 | 145,047 | |||||||||||
Net income attributable to Raymond James Financial, Inc. | $ | 112,755 | $ | 125,847 | $ | 259,322 | $ | 232,176 | |||||||
Other comprehensive income (loss), net of tax:(1) | |||||||||||||||
Unrealized gain (loss) on available for sale securities and non-credit portion of other-than-temporary impairment losses | 1,952 | 1,099 | (2,194 | ) | (5,692 | ) | |||||||||
Unrealized gain on currency translations, net of the impact of net investment hedges | 2,223 | 10,714 | 3,224 | 4,099 | |||||||||||
Unrealized gain (loss) on cash flow hedges | 1,531 | (11,469 | ) | 27,269 | (8,204 | ) | |||||||||
Total comprehensive income | $ | 118,461 | $ | 126,191 | $ | 287,621 | $ | 222,379 | |||||||
Other-than-temporary impairment: | |||||||||||||||
Total other-than-temporary impairment, net | $ | 397 | $ | (353 | ) | $ | 1,257 | $ | 21 | ||||||
Portion of (recoveries) losses recognized in other comprehensive income | (397 | ) | 353 | (1,257 | ) | (21 | ) | ||||||||
Net impairment losses recognized in other revenue | $ | — | $ | — | $ | — | $ | — |
(1) | All components of other comprehensive income (loss), net of tax, are attributable to Raymond James Financial, Inc. |
Six months ended March 31, | |||||||
2017 | 2016 | ||||||
(in thousands, except per share amounts) | |||||||
Common stock, par value $.01 per share: | |||||||
Balance, beginning of year | $ | 1,513 | $ | 1,491 | |||
Share issuances | 23 | 16 | |||||
Balance, end of period | 1,536 | 1,507 | |||||
Additional paid-in capital: | |||||||
Balance, beginning of year | 1,498,921 | 1,344,779 | |||||
Employee stock purchases | 12,741 | 18,938 | |||||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | 30,732 | 13,954 | |||||
Restricted stock, stock option and restricted stock unit expense | 52,288 | 39,962 | |||||
Excess tax benefit from share-based payments | — | (1) | 34,791 | ||||
Other | 632 | 362 | |||||
Balance, end of period | 1,595,314 | 1,452,786 | |||||
Retained earnings: (2) | |||||||
Balance, beginning of year | 3,834,781 | 3,422,169 | |||||
Net income attributable to Raymond James Financial, Inc. | 259,322 | 232,176 | |||||
Cash dividends declared | (66,176 | ) | (59,142 | ) | |||
Balance, end of period | 4,027,927 | 3,595,203 | |||||
Treasury stock: | |||||||
Balance, beginning of year | (362,937 | ) | (203,455 | ) | |||
Purchases/surrenders | (9,113 | ) | (152,284 | ) | |||
Exercise of stock options and vesting of restricted stock units, net of forfeitures | (17,545 | ) | (5,717 | ) | |||
Balance, end of period | (389,595 | ) | (361,456 | ) | |||
Accumulated other comprehensive loss: (3) | |||||||
Balance, beginning of year | (55,733 | ) | (40,503 | ) | |||
Net change in unrealized gain/loss on available for sale securities and non-credit portion of other-than-temporary impairment losses, net of tax | (2,194 | ) | (5,692 | ) | |||
Net change in currency translations and net investment hedges, net of tax | 3,224 | 4,099 | |||||
Net change in cash flow hedges, net of tax | 27,269 | (8,204 | ) | ||||
Balance, end of period | (27,434 | ) | (50,300 | ) | |||
Total equity attributable to Raymond James Financial, Inc. | $ | 5,207,748 | $ | 4,637,740 | |||
Noncontrolling interests: (2) | |||||||
Balance, beginning of year | $ | 146,431 | $ | 154,454 | |||
Net income attributable to noncontrolling interests | (3,074 | ) | (2,275 | ) | |||
Capital contributions | 9,776 | 695 | |||||
Distributions | (28,435 | ) | (5,033 | ) | |||
Derecognition resulting from sales | (4,628 | ) | — | ||||
Other | 399 | (2,187 | ) | ||||
Balance, end of period | 120,469 | 145,654 | |||||
Total equity | $ | 5,328,217 | $ | 4,783,394 |
(1) | During the six months ended March 31, 2017, we adopted new stock compensation simplification guidance. See Notes 1, 16 and 20 for additional information. |
(2) | Each respective prior period balance has been restated to reflect the impact of the deconsolidation of certain VIEs. See Note 1 for additional information. |
(3) | All components of other comprehensive (loss) income, net of tax, are attributable to Raymond James Financial, Inc. |
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) | |||||||
Six months ended March 31, | |||||||
2017 | 2016 | ||||||
(in thousands) | |||||||
Cash flows from operating activities: | |||||||
Net income attributable to Raymond James Financial, Inc. | $ | 259,322 | $ | 232,176 | |||
Net loss attributable to noncontrolling interests | (3,074 | ) | (2,275 | ) | |||
Net income including noncontrolling interests | 256,248 | 229,901 | |||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by (used in) operating activities: | |||||||
Depreciation and amortization | 40,959 | 35,652 | |||||
Deferred income taxes | (38,181 | ) | (13,295 | ) | |||
Premium and discount amortization on available for sale securities and unrealized/realized gain on other investments | (18,976 | ) | (3,852 | ) | |||
Provisions for loan losses, legal proceedings, bad debts and other accruals | 143,993 | 38,955 | |||||
Share-based compensation expense | 66,015 | 42,735 | |||||
Other | (2,067 | ) | 1,015 | ||||
Net change in: | |||||||
Assets segregated pursuant to regulations and other segregated assets | 1,054,930 | (704,005 | ) | ||||
Securities purchased under agreements to resell and other collateralized financings, net of securities sold under agreements to repurchase | (35,755 | ) | (96,577 | ) | |||
Stock loaned, net of stock borrowed | (235,408 | ) | 133,120 | ||||
Loans provided to financial advisors, net of repayments | (33,945 | ) | (70,836 | ) | |||
Brokerage client receivables and other accounts receivable, net | 23,233 | (136,374 | ) | ||||
Trading instruments, net | 174,079 | (16,708 | ) | ||||
Prepaid expenses and other assets | 158,758 | 129,318 | |||||
Brokerage client payables and other accounts payable | (431,259 | ) | 605,528 | ||||
Accrued compensation, commissions and benefits | (108,250 | ) | (168,896 | ) | |||
Proceeds from sales of securitizations and loans held for sale, net of purchases and originations of loans held for sale | 77,765 | (63,180 | ) | ||||
Net cash provided by (used in) operating activities | 1,092,139 | (57,499 | ) | ||||
Cash flows from investing activities: | |||||||
Additions to property and equipment | (123,338 | ) | (58,180 | ) | |||
Increase in bank loans, net | (1,103,445 | ) | (1,490,887 | ) | |||
Purchases of Federal Home Loan Bank/Federal Reserve Bank stock | (4,875 | ) | (3,231 | ) | |||
Proceeds from sales of loans held for investment | 106,223 | 65,443 | |||||
Purchases, or contributions, to private equity or other investments, net of proceeds from sales of, or distributions received from, private equity and other investments | 51,455 | (60,639 | ) | ||||
Purchases of available for sale securities | (1,012,238 | ) | (87,676 | ) | |||
Available for sale securities maturations, repayments and redemptions | 115,976 | 42,729 | |||||
Proceeds from sales of available for sale securities | 32,841 | 1,530 | |||||
Other investing activities, net of proceeds received | 2,399 | 4,432 | |||||
Net cash used in investing activities | $ | (1,935,002 | ) | $ | (1,586,479 | ) | |
(continued on next page) | |||||||
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited). | |||||||
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (continued from previous page) | |||||||
Six months ended March 31, | |||||||
2017 | 2016 | ||||||
(in thousands) | |||||||
Cash flows from financing activities: | |||||||
Proceeds from (repayments of) short-term borrowings, net | $ | 50,000 | $ | (115,000 | ) | ||
Proceeds from Federal Home Loan Bank advances | 100,000 | 25,000 | |||||
Repayments of Federal Home Loan Bank advances and other borrowed funds | (2,291 | ) | (2,181 | ) | |||
Repayment of senior notes payable | (350,000 | ) | — | ||||
Exercise of stock options and employee stock purchases | 43,989 | 31,240 | |||||
Increase in bank deposits | 2,114,997 | 809,576 | |||||
Purchases of treasury stock | (29,063 | ) | (159,175 | ) | |||
Dividends on common stock | (63,027 | ) | (56,152 | ) | |||
Net cash provided by financing activities | 1,864,605 | 533,308 | |||||
Currency adjustment: | |||||||
Effect of exchange rate changes on cash | (35,868 | ) | (10,550 | ) | |||
Net increase (decrease) in cash and cash equivalents | 985,874 | (1,121,220 | ) | ||||
Cash and cash equivalents at beginning of year | 1,650,452 | 2,601,006 | |||||
Cash and cash equivalents at end of period | $ | 2,636,326 | $ | 1,479,786 | |||
Supplemental disclosures of cash flow information: | |||||||
Cash paid for interest | $ | 76,990 | $ | 55,548 | |||
Cash paid for income taxes | $ | 144,672 | $ | 124,521 | |||
Non-cash transfers of loans to other real estate owned | $ | 2,777 | $ | 1,942 |
Three months ended March 31, | Six months ended March 31, | ||||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||||
(in thousands) | |||||||||||||||||
Acquisition and integration related incentive compensation costs(1) | $ | — | $ | — | $ | 5,474 | $ | — | |||||||||
Severance(2) | 754 | — | 5,557 | — | |||||||||||||
Early termination costs of assumed contracts | 5 | — | 1,329 | — | |||||||||||||
Information systems integration costs | 417 | 1,655 | 1,622 | 1,655 | |||||||||||||
Legal and regulatory | 274 | 422 | 827 | 1,923 | |||||||||||||
Post-closing purchase price contingency | (1,248 | ) | — | (3,499 | ) | — | |||||||||||
DBRSU obligation and related hedge(3) | 798 | 3,165 | (4) | 798 | 3,319 | (4) | |||||||||||
Travel and all other | 86 | 773 | 1,644 | 990 | |||||||||||||
Total acquisition-related expenses | $ | 1,086 | $ | 6,015 | $ | 13,752 | $ | 7,887 |
(1) | Primarily comprised of non-recurring restricted stock unit (“RSU”) grants authorized by the Board of Directors in their November 2016 meeting, made to certain employees and consultants for acquisition-related purposes. See Note 20 for discussion of share-based compensation. |
(2) | Primarily arising from the 3Macs acquisition. Such costs include severance costs as well as any forgiven employee loan balances and any unamortized balance of the prepaid compensation asset associated with terminated associates, which will not be collected (refer to the discussion of this prepaid asset in Note 3 on page 128, and Note 10 on page 157, each in our 2016 Form 10-K). |
(3) | The three and six months ended March 31, 2017 include a loss on the Deutsche Bank RSU (“DBRSU”) awards related to a Deutsche Bank AG (“DB”) rights offering during the period, partially offset by a related gain on the DB shares purchased to satisfy the DBRSU obligation, which act as an economic hedge to this obligation. Refer to Note 3 on page 129 of our 2016 Form 10-K, as well as Notes 14 and 20 in this Form 10-Q for more information. |
(4) | Represents the pre-Alex. Brown closing date unrealized loss on DB shares purchased to satisfy the DBRSU obligation. |
March 31, 2017 | September 30, 2016 | ||||||
(in thousands) | |||||||
Cash and cash equivalents: | |||||||
Cash in banks | $ | 2,634,934 | $ | 1,649,593 | |||
Money market fund investments | 1,392 | 859 | |||||
Total cash and cash equivalents (1) | $ | 2,636,326 | $ | 1,650,452 | |||
Assets segregated pursuant to regulations and other segregated assets (2) | $ | 3,829,607 | $ | 4,884,487 | |||
Deposits with clearing organizations: | |||||||
Cash and cash equivalents | $ | 148,712 | $ | 215,856 | |||
Government and agency obligations | 50,384 | 29,508 | |||||
Total deposits with clearing organizations | $ | 199,096 | $ | 245,364 |
(1) | The total amounts presented include cash and cash equivalents of $924 million and $810 million as of March 31, 2017 and September 30, 2016, respectively, which are either held directly by RJF in depository accounts at third party financial institutions, held in a depository account at RJ Bank, or are otherwise invested by one of our subsidiaries on behalf of RJF, all of which are available without restrictions. |
(2) | Consists of cash maintained in accordance with Rule 15c3-3 under the Securities Exchange Act of 1934. RJ&A, as a broker-dealer carrying client accounts, is subject to requirements to maintain cash or qualified securities in segregated reserve accounts for the exclusive benefit of its clients. Additionally, RJ Ltd. is required to hold client Registered Retirement Savings Plan funds in trust. |
March 31, 2017 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of March 31, 2017 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
Assets at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 55 | $ | 239,752 | $ | — | $ | — | $ | 239,807 | ||||||||||
Corporate obligations | 11,574 | 117,130 | — | — | 128,704 | |||||||||||||||
Government and agency obligations | 7,230 | 72,779 | — | — | 80,009 | |||||||||||||||
Agency mortgage-backed securities (“MBS”) and collateralized mortgage obligations (“CMOs”) | 394 | 136,658 | — | — | 137,052 | |||||||||||||||
Non-agency CMOs and asset-backed securities (“ABS”) | — | 56,397 | 7 | — | 56,404 | |||||||||||||||
Total debt securities | 19,253 | 622,716 | 7 | — | 641,976 | |||||||||||||||
Derivative contracts | — | 73,771 | — | (45,705 | ) | 28,066 | ||||||||||||||
Equity securities | 20,160 | 970 | — | — | 21,130 | |||||||||||||||
Brokered certificates of deposit | — | 32,445 | — | — | 32,445 | |||||||||||||||
Other | 24 | — | 13,141 | — | 13,165 | |||||||||||||||
Total trading instruments | 39,437 | 729,902 | 13,148 | (45,705 | ) | 736,782 | ||||||||||||||
Available for sale securities: | ||||||||||||||||||||
Agency MBS and CMOs | — | 1,547,579 | — | — | 1,547,579 | |||||||||||||||
Non-agency CMOs | — | 33,837 | — | — | 33,837 | |||||||||||||||
Other securities | 1,552 | — | — | — | 1,552 | |||||||||||||||
Auction rate securities (“ARS”): | ||||||||||||||||||||
Municipal obligations | — | — | 25,728 | — | 25,728 | |||||||||||||||
Preferred securities | — | — | 105,418 | — | 105,418 | |||||||||||||||
Total available for sale securities | 1,552 | 1,581,416 | 131,146 | — | 1,714,114 | |||||||||||||||
Private equity investments: | ||||||||||||||||||||
Measured at fair value | — | — | 88,623 | — | 88,623 | |||||||||||||||
Measured at net asset value (“NAV”) | 113,138 | |||||||||||||||||||
Total private equity investments | — | — | 88,623 | — | 201,761 | |||||||||||||||
Other investments (3) | 221,889 | 322 | 374 | — | 222,585 | |||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 285,898 | — | — | 285,898 | |||||||||||||||
Deposits with clearing organizations: | ||||||||||||||||||||
Government and agency obligations | 50,384 | — | — | — | 50,384 | |||||||||||||||
Other assets: | ||||||||||||||||||||
Derivative contracts (4) | — | 276 | — | — | 276 | |||||||||||||||
Other assets | — | — | 2,148 | (5) | — | 2,148 | ||||||||||||||
Total other assets | — | 276 | 2,148 | — | 2,424 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 313,262 | $ | 2,597,814 | $ | 235,439 | $ | (45,705 | ) | $ | 3,213,948 | |||||||||
Assets at fair value on a nonrecurring basis: | ||||||||||||||||||||
Bank loans, net: | ||||||||||||||||||||
Impaired loans | $ | — | $ | 20,670 | $ | 41,081 | $ | — | $ | 61,751 | ||||||||||
Loans held for sale(6) | — | 60,538 | — | — | 60,538 | |||||||||||||||
Total bank loans, net | — | 81,208 | 41,081 | — | 122,289 | |||||||||||||||
Other assets: Other real estate owned (“OREO”)(7) | — | 790 | — | — | 790 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 81,998 | $ | 41,081 | $ | — | $ | 123,079 | ||||||||||
(continued on next page) |
March 31, 2017 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of March 31, 2017 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
(continued from previous page) | ||||||||||||||||||||
Liabilities at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments sold but not yet purchased: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 600 | $ | 470 | $ | — | $ | — | $ | 1,070 | ||||||||||
Corporate obligations | 1,021 | 22,484 | — | — | 23,505 | |||||||||||||||
Government obligations | 328,609 | — | — | — | 328,609 | |||||||||||||||
Agency MBS and CMOs | 1,866 | 43,778 | — | — | 45,644 | |||||||||||||||
Total debt securities | 332,096 | 66,732 | — | — | 398,828 | |||||||||||||||
Derivative contracts | — | 91,247 | — | (35,215 | ) | 56,032 | ||||||||||||||
Equity securities | 16,618 | — | — | — | 16,618 | |||||||||||||||
Other securities | — | 226 | — | — | 226 | |||||||||||||||
Total trading instruments sold but not yet purchased | 348,714 | 158,205 | — | (35,215 | ) | 471,704 | ||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 285,898 | — | — | 285,898 | |||||||||||||||
Trade and other payables: | ||||||||||||||||||||
Derivative contracts (4) | — | 6,868 | — | — | 6,868 | |||||||||||||||
Other liabilities | — | — | 64 | — | 64 | |||||||||||||||
Total trade and other payables | — | 6,868 | 64 | — | 6,932 | |||||||||||||||
Accrued compensation, commissions and benefits: | ||||||||||||||||||||
Derivative contracts (8) | — | 25,621 | — | — | 25,621 | |||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 348,714 | $ | 476,592 | $ | 64 | $ | (35,215 | ) | $ | 790,155 |
(1) | We had $1 million and $2 million in transfers of financial instruments from Level 1 to Level 2 during the three and six months ended March 31, 2017, respectively. These transfers were a result of decreased market activity in these instruments. Our transfers from Level 2 to Level 1 were insignificant during the three months ended March 31, 2017 and amounted to $1 million during the six months ended March 31, 2017. These transfers were a result of increased market activity in these instruments. Our policy is to treat transfers between levels as having occurred at the end of the reporting period. |
(2) | For derivative transactions, where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. See Note 14 for additional information on the collateral related to our derivative contracts and Note 15 for information on offsetting financial instruments. |
(3) | Other investments include $79 million of financial instruments that are related to obligations to perform under certain deferred compensation plans (see Note 2 on page 116, and Note 24 on pages 186 - 191, of our 2016 Form 10-K, for further information regarding these plans), and DB shares with a fair value of $19 million as of March 31, 2017 which we hold as an economic hedge against the DBRSU obligation (see Note 20 for additional information). |
(4) | Consists of derivatives arising from RJ Bank’s business operations, see Note 14 for additional information. |
(5) | Includes the fair value of forward commitments to purchase GNMA or FNMA (as hereinafter defined) MBS arising from our fixed income public finance operations. See Note 2 and Note 21 of our 2016 Form 10-K for additional information. |
(6) | Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost. |
(7) | Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Condensed Consolidated Statements of Financial Condition is net of the estimated selling costs. |
(8) | The balance reflects the DBRSU obligation from our acquisition of Alex. Brown. See Notes 14 and 20 for additional information. |
September 30, 2016 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of September 30, 2016 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
Assets at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 480 | $ | 273,683 | $ | — | $ | — | $ | 274,163 | ||||||||||
Corporate obligations | 10,000 | 122,885 | — | — | 132,885 | |||||||||||||||
Government and agency obligations | 6,412 | 43,186 | — | — | 49,598 | |||||||||||||||
Agency MBS and CMOs | 413 | 164,250 | — | — | 164,663 | |||||||||||||||
Non-agency CMOs and ABS | — | 34,421 | 7 | — | 34,428 | |||||||||||||||
Total debt securities | 17,305 | 638,425 | 7 | — | 655,737 | |||||||||||||||
Derivative contracts | — | 163,242 | — | (107,539 | ) | 55,703 | ||||||||||||||
Equity securities | 14,529 | 1,500 | — | — | 16,029 | |||||||||||||||
Brokered certificates of deposit | — | 35,206 | — | — | 35,206 | |||||||||||||||
Other | 555 | 3 | 3,572 | — | 4,130 | |||||||||||||||
Total trading instruments | 32,389 | 838,376 | 3,579 | (107,539 | ) | 766,805 | ||||||||||||||
Available for sale securities: | ||||||||||||||||||||
Agency MBS and CMOs | — | 682,297 | — | — | 682,297 | |||||||||||||||
Non-agency CMOs | — | 50,519 | — | — | 50,519 | |||||||||||||||
Other securities | 1,417 | — | — | — | 1,417 | |||||||||||||||
ARS: | ||||||||||||||||||||
Municipal obligations | — | — | 25,147 | — | 25,147 | |||||||||||||||
Preferred securities | — | — | 100,018 | — | 100,018 | |||||||||||||||
Total available for sale securities | 1,417 | 732,816 | 125,165 | — | 859,398 | |||||||||||||||
Private equity investments: | ||||||||||||||||||||
Measured at fair value | — | — | 83,165 | — | 83,165 | |||||||||||||||
Measured at NAV | 111,469 | |||||||||||||||||||
Total private equity investments | — | — | 83,165 | — | 194,634 | |||||||||||||||
Other investments (3) | 296,146 | 257 | 441 | — | 296,844 | |||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 422,196 | — | — | 422,196 | |||||||||||||||
Deposits with clearing organizations: | ||||||||||||||||||||
Government and agency obligations | 29,508 | — | — | — | 29,508 | |||||||||||||||
Other assets: | ||||||||||||||||||||
Derivative contracts (4) | — | 2,016 | — | — | 2,016 | |||||||||||||||
Other assets | — | — | 2,448 | (5) | — | 2,448 | ||||||||||||||
Total other assets | — | 2,016 | 2,448 | — | 4,464 | |||||||||||||||
Total assets at fair value on a recurring basis | $ | 359,460 | $ | 1,995,661 | $ | 214,798 | $ | (107,539 | ) | $ | 2,573,849 | |||||||||
Assets at fair value on a nonrecurring basis: | ||||||||||||||||||||
Bank loans, net: | ||||||||||||||||||||
Impaired loans | $ | — | $ | 23,146 | $ | 47,982 | $ | — | $ | 71,128 | ||||||||||
Loans held for sale (6) | — | 18,177 | — | — | 18,177 | |||||||||||||||
Total bank loans, net | — | 41,323 | 47,982 | — | 89,305 | |||||||||||||||
Other assets: OREO (7) | — | 679 | — | — | 679 | |||||||||||||||
Total assets at fair value on a nonrecurring basis | $ | — | $ | 42,002 | $ | 47,982 | $ | — | $ | 89,984 | ||||||||||
(continued on next page) |
September 30, 2016 | Quoted prices in active markets for identical assets (Level 1) (1) | Significant other observable inputs (Level 2) (1) | Significant unobservable inputs (Level 3) | Netting adjustments (2) | Balance as of September 30, 2016 | |||||||||||||||
(in thousands) | ||||||||||||||||||||
(continued from previous page) | ||||||||||||||||||||
Liabilities at fair value on a recurring basis: | ||||||||||||||||||||
Trading instruments sold but not yet purchased: | ||||||||||||||||||||
Municipal and provincial obligations | $ | 1,161 | $ | — | $ | — | $ | — | $ | 1,161 | ||||||||||
Corporate obligations | 1,283 | 29,791 | — | — | 31,074 | |||||||||||||||
Government obligations | 266,682 | — | — | — | 266,682 | |||||||||||||||
Agency MBS and CMOs | 2,804 | — | — | — | 2,804 | |||||||||||||||
Total debt securities | 271,930 | 29,791 | — | — | 301,721 | |||||||||||||||
Derivative contracts | — | 151,694 | — | (142,859 | ) | 8,835 | ||||||||||||||
Equity securities | 18,382 | — | — | — | 18,382 | |||||||||||||||
Total trading instruments sold but not yet purchased | 290,312 | 181,485 | — | (142,859 | ) | 328,938 | ||||||||||||||
Derivative instruments associated with offsetting matched book positions | — | 422,196 | — | — | 422,196 | |||||||||||||||
Trade and other payables: | ||||||||||||||||||||
Derivative contracts (4) | — | 26,671 | — | — | 26,671 | |||||||||||||||
Other liabilities | — | — | 67 | — | 67 | |||||||||||||||
Total trade and other payables | — | 26,671 | 67 | — | 26,738 | |||||||||||||||
Accrued compensation, commissions and benefits: | ||||||||||||||||||||
Derivative contracts (8) | — | 17,769 | — | — | 17,769 | |||||||||||||||
Total liabilities at fair value on a recurring basis | $ | 290,312 | $ | 648,121 | $ | 67 | $ | (142,859 | ) | $ | 795,641 |
(1) | We had $3 million in transfers of financial instruments from Level 1 to Level 2 during the year ended September 30, 2016. These transfers were a result of decreased market activity in these instruments. We had $1 million in transfers of financial instruments from Level 2 to Level 1 during the year ended September 30, 2016. These transfers were a result of an increased market activity in these instruments. Our policy is to treat transfers between levels of the fair value hierarchy as having occurred at the end of the reporting period. |
(2) | For derivative transactions not cleared through a clearing organization, and where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists (see Note 15 for additional information regarding offsetting financial instruments). Deposits associated with derivative transactions cleared through a clearing organization are included in deposits with clearing organizations on our Condensed Consolidated Statements of Financial Condition as of September 30, 2016. |
(3) | Other investments include $77 million of financial instruments that are related to obligations to perform under certain deferred compensation plans (see Note 2 and Note 24, of our 2016 Form 10-K for further information regarding these plans), and DB shares with a fair value of $12 million as of September 30, 2016 which we hold as an economic hedge against the DBRSU obligation (see Notes 2, 18, and 24 of our 2016 Form 10-K for additional information). |
(4) | Consists of derivatives arising from RJ Bank’s business operations, see Note 14 for additional information. |
(5) | Includes the fair value of forward commitments to purchase GNMA or FNMA (as hereinafter defined) MBS arising from our fixed income public finance operations. See Note 2 and Note 21 of our 2016 Form 10-K for additional information. |
(6) | Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost. |
(7) | Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Consolidated Statements of Financial Condition is net of the estimated selling costs. |
(8) | The balance reflects the DBRSUs obligation from our acquisition of Alex. Brown. See Notes 14 and 20 for additional information. |
Three months ended March 31, 2017 Level 3 assets at fair value (in thousands) | |||||||||||||||||||||||||||||||
Financial assets | Financial liabilities | ||||||||||||||||||||||||||||||
Trading instruments | Available for sale securities | Private equity, other investments and other assets | Payables- trade and other | ||||||||||||||||||||||||||||
Non- agency CMOs & ABS | Other | ARS – municipal obligations | ARS - preferred securities |